← Dashboard
Stock
EVO
Evotec SELatest close $2.743 of 27 marquee funds currently hold1 CUSIP mapped
Current holders
3
27 funds tracked
Ever held
3
Current + past
New this quarter
0
Exited this quarter
0
Marquee-fund ownership over time
Aug 14, 2024Feb 14, 2025Aug 14, 2025Feb 17, 2026
Now
3
Current holders
Sorted by tenure (longest first)| Fund | First disclosed | Held | Entry price | Latest close | Return on entry |
|---|---|---|---|---|---|
| Citadel Advisors re-entered | Q3 2024(8Q snapshot) | 7Q | $3.31 | $2.74 | -17% |
| Millennium Management re-entered | Q3 2024(8Q snapshot) | 7Q | $3.31 | $2.74 | -17% |
| Point72 Asset Management | Q1 2026(8Q snapshot) | 1Q | $3.53 | $2.74 | -22% |
“Return on entry” is the price-only move from the fund's first disclosure to today — it ignores any adds, trims, or dividends. A fund that built its position over multiple quarters has a true cost basis somewhere between entry price and latest close; this figure is the upper bound.
Fundamentals
XBRL · Evotec SENot enough XBRL history to plot. Evotec SEhasn't tagged revenue, net income, EPS, or operating cash flow in the SEC us-gaap taxonomy with at least two fiscal-year periods — typical for SPACs / trust vehicles, pre-revenue biotechs, recent IPOs, and foreign filers reporting under IFRS.
Recent SEC filings
10-K · 10-Q · 8-K · 13D/G · proxyThe most recent material filings for Evotec SE — earnings, material events, ownership disclosures, proxy statements. Form 4 insider activity is shown in the panel above.
- 6-KFORM 6-KMay 6, 2026
- 6-KFORM 6-KApr 30, 2026
- 6-KFORM 6-KApr 24, 2026
- 6-KFORM 6-KApr 8, 2026
- 20-FFORM 20-FApr 8, 2026
- 6-KFORM 6-KApr 7, 2026
- 6-KFORM 6-KMar 10, 2026
- 6-KFORM 6-KJan 16, 2026
- 6-KFORM 6-KJan 13, 2026
- 6-KFORM 6-KJan 8, 2026
- 6-KFORM 6-KJan 6, 2026
- 6-KFORM 6-KJan 2, 2026
- 6-KFORM 6-KJan 2, 2026
- 6-KFORM 6-KDec 8, 2025
- 6-KFORM 6-KNov 6, 2025
Trade history
Every open→close lifecycle across tracked funds| Fund | Open date | Close date | Open price | Close price / current | Return |
|---|---|---|---|---|---|
| Millennium Management | Q1 2026 | open | $3.53 | $2.74 | -22% |
| Point72 Asset Management | Q1 2026 | open | $3.53 | $2.74 | -22% |
| Citadel Advisors | Q3 2025 | open | $3.82 | $2.74 | -28% |
| Citadel Advisors | Q3 2024 | Q1 2025 | $3.31 | $4.58 | +38% |
| Millennium Management | Q3 2024 | Q1 2025 | $3.31 | $4.58 | +38% |
Caveats
- Covers only the 27 marquee funds tracked here, not the full institutional universe. A “0 holders” reading does not mean unowned.
- Heavy funds (Renaissance Technologies, Citadel Advisors, Soros Fund Management, Two Sigma Investments, D.E. Shaw, AQR Capital Management, Millennium Management, Point72 Asset Management) use 8-quarter snapshots, so their pre-2024 history is missing.
- “Current” reflects each fund's most recent 13F — filings lag the actual trade by up to 45 days; positions shown may have changed since.
- Cost = price at the entry filing date. Re-entered positions show the most recent open lot.
- Options, ADRs, and unmapped CUSIPs are excluded from the follower-backtest pipeline that produces these snapshots, so certain holding types won't appear here.